Exposure-response analyses of sacituzumab govitecan (SG) efficacy and safety in patients (pts) with metastatic triple-negative breast cancer (mTNBC).

Indrajeet Singh,Abhishek G. Sathe,Pratap Singh, Paul M. Diderichsen, Floris Fauchet, John Maringwa,Philippe Pierrillas, See-Chun Phan,Sandhya Girish,Ahmed A. Othman

JOURNAL OF CLINICAL ONCOLOGY(2022)

引用 0|浏览7
暂无评分
关键词
breast cancer,sacituzumab govitecan,metastatic,exposure-response,triple-negative
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要